Adma Biologics reported $14.12M in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Adamis Pharmaceuticals ADMP:US 4.89M 1.14M
Adma Biologics ADMA:US $ 14.12M 1.69M
Agile Therapeutics AGRX:US 9.54M 830K
Alnylam Pharmaceuticals ALNY:US $ 54.92M 18.51M
Biocryst Pharmaceuticals BCRX:US $ 13.88M 13.93M
China Cord Blood CO:US 11.67M 1.77M
Dynavax Technologies DVAX:US $ 20.19M 17.59M
Minerva Neurosciences NERV:US $ 1.59M 0.27M
Novavax NVAX:US $ 135.13M 8.08M
Omeros OMER:US $ 7.34M 6.06M
Takeda 4502:JP Y 516297M 165112M